Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H11NO |
Molecular Weight | 101.1469 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CC(N)=O
InChI
InChIKey=SANOUVWGPVYVAV-UHFFFAOYSA-N
InChI=1S/C5H11NO/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H2,6,7)
Isovaleramide (also known as NPS 1776) is one of the active anticonvulsant constituents of Valeriana pavonii, it was suggested, isovaleramide can be a positive allosteric modulator of the GABAA receptor. This drug was studied in clinical trials for the treatment of A migraine, epilepsy and some others CNS disorders, but these studies were discontinued.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2109243 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20890571 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00172094
single oral dose 400 mg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20890571
isovaleramide (300 µM) exhibited a 42% of inhibition of the binding of ³H-FNZ to its sites.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
541-46-8
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
Isovaleramide
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
CHEMBL171066
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
9CP4KB634M
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
208-781-1
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
300000044620
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
m6546
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | Merck Index | ||
|
C76507
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
RR-08
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
C038165
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
402555
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
DTXSID3060249
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY | |||
|
10930
Created by
admin on Fri Dec 15 15:54:59 GMT 2023 , Edited by admin on Fri Dec 15 15:54:59 GMT 2023
|
PRIMARY |
ACTIVE MOIETY